Mirxes

Local SME to mass-produce Sars-CoV-2 diagnostic test kits

LOCAL medtech firm MiRXES will take charge of mass-producing locally-developed diagnostic test kits for the novel coronavirus, as Singapore prepares to meet high levels of demand both locally and...

Medtech firm Ark launched with US$40m Series A funding

IN A BOLD move for venture capital firms in the region, Singapore's Venturecraft has merged with medtech startup Mirxes to form Ark Bio, a cancer detection company armed with a US$40 million...

Startup creates alternative test for cancer

CURRENT cancer screening methods are invasive and costly. Think of the mammographies, endoscopies, or biopsies that are presently done to detect cancer. Local biotechnology start-up Mirxes Pte Ltd is...